Show simple item record

dc.contributor.authorJordan Hollman
dc.contributor.authorMuhammad Faizan Khan
dc.contributor.authorJohn Albino Dominic
dc.contributor.authorGopal Achari
dc.date.accessioned2022-01-30T21:34:49Z
dc.date.available2022-01-30T21:34:49Z
dc.date.issued11/1/2020 12:00:00 AM
dc.identifier.other%28ASCE%29EE.1943-7870.0001777.pdf
dc.identifier.urihttp://yetl.yabesh.ir/yetl1/handle/yetl/4268471
dc.description.abstractPharmaceutically active compounds (PhACs) reaching surface waters through municipal wastewater are a concern, as existing treatment processes poorly remove them. While significant lab-scale evaluations have been performed on treatment options, full-scale tests are lacking. Presented is an experimental study from a full-scale research facility that is imbedded in a functioning municipal wastewater plant. Reverse osmosis and ozonation were tested as part of an active treatment train using secondary treated effluent from the adjoining facility. Reverse osmosis removed 92.6%, 99.0%, 99.6%, 97.8%, 99.0%, 99.6%, 99.9%, and 99.2% of metformin, cotinine, trimethoprim, caffeine, venlafaxine, carbamazepine, erythromycin, and fluoxetine, respectively. By ozone, sulfamethoxazole, carbamazepine, erythromycin and o-desmethylvenlafaxine were removed by more than 99.9%. Trimethoprim and venlafaxine were removed by more than 95%, with the remaining compounds removed by between 16% and 85%. Results demonstrate the effectiveness of reverse osmosis and ozonation for full-scale treatment.
dc.publisherASCE
dc.titlePilot-Scale Treatment of Neutral Pharmaceuticals in Municipal Wastewater Using Reverse Osmosis and Ozonation
dc.typeJournal Paper
dc.journal.volume146
dc.journal.issue11
dc.journal.titleJournal of Environmental Engineering
dc.identifier.doi10.1061/(ASCE)EE.1943-7870.0001777
dc.page10
dc.treeJournal of Environmental Engineering:;2020:;Volume ( 146 ):;issue: 011
dc.contenttypeFulltext


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record